Outlook Therapeutics Inc (NASDAQ:OTLK)

2.10
Delayed Data
As of Oct 15
 0.00 / 0.00%
Today’s Change
0.69
Today|||52-Week Range
4.26
+61.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-48.7M-53.3M-38.8M-30.1M
 
 
 
 
 
Depreciation1.8M2.4M2.7M3.1M
 
 
 
 
 
Total Other Cash Flow11.2M12.5M9.5M7.7M
 
 
 
 
 
Funds From Operations-35.7M-38.5M-26.7M-19.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-8.2M7.0M-11.2M13.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-27.5M-45.5M-15.5M-33.0M
 
 
 
 
 
 
InvestingIncrease In Investments-2.2K0.000.00--
 
 
Capital Expenditures-8.8M-1.1M-292.1K-2.8M
 
 
 
 
 
Fixed Asset Disposal401.0K------
 
 
Net Cash Flow Investing-8.4M-1.1M-292.1K-2.8M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings10.9M200.4K15.0M0.00
 
 
 
 
Long Term Debt Reduction-9.3M-13.5M-3.7M-990.6K
 
 
 
 
 
Net Proceeds Stock Sale41.2M48.6M5.1M36.4M
 
 
 
 
 
Common Preferred Redeemed-226.0K0.000.00-1.1M
 
 
 
Common Dividends------0.00--
Cash Dividends Paid - Total------0.00--
Other Sources - Financing0.005.1M216.1K0.00
 
 
 
Other Uses - Financing0.00475.3K0.000.00
 
 
Net Cash Flow - Financing42.6M39.9M16.6M34.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash6.7M-6.7M833.6K-1.5M